A Phase II Study of Abraxane Combined With Gemcitabine in the Patients With Metastatic Breast Cancer
This study is to investigate the efficacy and toxicity of Abraxane combined with Gemcitabine
in the patients with metastatic breast cancer.
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
overall response rate
Xichun Hu, MD;PhD
China: Ethics Committee